MRNA logo

Moderna, Inc. (MRNA) Cash From Investing

Annual CFI:

$1.95B-$2.26B(-53.66%)
December 31, 2024

Summary

  • As of today, MRNA annual cash from investing is $1.95 billion, with the most recent change of -$2.26 billion (-53.66%) on December 31, 2024.
  • During the last 3 years, MRNA annual cash from investing has risen by +$10.47 billion (+122.87%).
  • MRNA annual cash from investing is now -53.66% below its all-time high of $4.21 billion, reached on December 31, 2023.

Performance

MRNA Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMRNAcash flow metrics

Quarterly CFI:

$700.00M+$136.00M(+24.11%)
September 30, 2025

Summary

  • As of today, MRNA quarterly cash from investing is $700.00 million, with the most recent change of +$136.00 million (+24.11%) on September 30, 2025.
  • Over the past year, MRNA quarterly cash from investing has dropped by -$21.00 million (-2.91%).
  • MRNA quarterly cash from investing is now -65.19% below its all-time high of $2.01 billion, reached on March 31, 2023.

Performance

MRNA Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMRNAcash flow metrics

TTM CFI:

$1.46B-$21.00M(-1.42%)
September 30, 2025

Summary

  • As of today, MRNA TTM cash from investing is $1.46 billion, with the most recent change of -$21.00 million (-1.42%) on September 30, 2025.
  • Over the past year, MRNA TTM cash from investing has dropped by -$495.00 million (-25.38%).
  • MRNA TTM cash from investing is now -65.41% below its all-time high of $4.21 billion, reached on December 31, 2023.

Performance

MRNA TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMRNAcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

MRNA Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-53.7%-2.9%-25.4%
3Y3 Years+122.9%-25.9%+127.6%
5Y5 Years+10000.0%+159.4%+207.7%

MRNA Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-53.7%+122.9%-65.2%+166.8%-65.4%+127.6%
5Y5-Year-53.7%+122.9%-65.2%+117.8%-65.4%+111.9%
All-TimeAll-Time-53.7%+122.9%-65.2%+117.8%-65.4%+111.9%

MRNA Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2025
-
$700.00M(+24.1%)
$1.46B(-1.4%)
Jun 2025
-
$564.00M(-22.7%)
$1.48B(-42.4%)
Mar 2025
-
$730.00M(+235.4%)
$2.56B(+31.4%)
Dec 2024
$1.95B(-53.7%)
-$539.00M(-174.8%)
$1.95B(-0.1%)
Sep 2024
-
$721.00M(-56.3%)
$1.95B(-3.4%)
Jun 2024
-
$1.65B(+1297.5%)
$2.02B(-12.8%)
Mar 2024
-
$118.00M(+121.9%)
$2.31B(-45.0%)
Dec 2023
$4.21B(+181.3%)
-$538.00M(-168.2%)
$4.21B(+13.8%)
Sep 2023
-
$789.00M(-59.4%)
$3.70B(-4.0%)
Jun 2023
-
$1.94B(-3.3%)
$3.85B(+409.5%)
Mar 2023
-
$2.01B(+291.9%)
$756.00M(+114.6%)
Dec 2022
-$5.18B(+39.3%)
-$1.05B(-210.9%)
-$5.18B(+1.7%)
Sep 2022
-
$945.00M(+182.0%)
-$5.27B(+44.8%)
Jun 2022
-
-$1.15B(+70.6%)
-$9.54B(+22.2%)
Mar 2022
-
-$3.92B(-244.6%)
-$12.26B(-43.9%)
Dec 2021
-$8.52B(-409.7%)
-$1.14B(+65.8%)
-$8.52B(-12.5%)
Sep 2021
-
-$3.33B(+14.2%)
-$7.58B(-39.6%)
Jun 2021
-
-$3.88B(-2054.4%)
-$5.43B(-253.3%)
Mar 2021
-
-$180.00M(+5.3%)
-$1.54B(+8.1%)
Dec 2020
-$1.67B(>-9900.0%)
-$190.13M(+83.9%)
-$1.67B(-23.7%)
Sep 2020
-
-$1.18B(-9541.9%)
-$1.35B(-2159.0%)
Jun 2020
-
$12.48M(+103.9%)
-$59.82M(+81.3%)
Mar 2020
-
-$316.02M(-342.4%)
-$319.20M(-2035.9%)
Dec 2019
-$15.00M(+96.0%)
$130.35M(+15.0%)
-$14.95M(+89.2%)
Sep 2019
-
$113.37M(+145.9%)
-$138.88M(-2.0%)
Jun 2019
-
-$246.90M(-1999.7%)
-$136.17M(-236.9%)
Mar 2019
-
-$11.76M(-283.5%)
$99.47M(+126.7%)
Dec 2018
-$373.09M(-189.4%)
$6.41M(-94.5%)
-$372.47M(-40.0%)
Sep 2018
-
$116.08M(+1131.0%)
-$266.08M(+30.4%)
Jun 2018
-
-$11.26M(+97.7%)
-$382.24M(-3.0%)
Mar 2018
-
-$483.70M(-528.8%)
-$371.28M(-430.2%)
Dec 2017
$417.36M(+164.3%)
$112.80M(>+9900.0%)
$112.42M(>+9900.0%)
Sep 2017
-
-$75.00K(+75.0%)
-$369.10K(-25.5%)
Jun 2017
-
-$300.00K(-5184.7%)
-$294.10K(-5084.7%)
Dec 2016
-$648.61M(>-9900.0%)
-
-
Dec 2016
-
$5900.00(>+9900.0%)
$5900.00(>+9900.0%)
Sep 2016
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2016
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2015
-$45.00K(>-9900.0%)
-
-
Dec 2014
$0.00(-100.0%)
-
-
Dec 2013
$410.00K(-61.4%)
$0.00(0.0%)
$410.00K(-47.6%)
Sep 2013
-
$0.00(-100.0%)
$782.00K(-42.2%)
Jun 2013
-
$30.00K(-92.1%)
$1.35M(-4.5%)
Mar 2013
-
$380.00K(+2.2%)
$1.42M(+33.3%)
Dec 2012
$1.06M(>+9900.0%)
$372.00K(-34.7%)
$1.06M(+27.5%)
Sep 2012
-
$570.00K(+506.4%)
$833.00K(+216.7%)
Jun 2012
-
$94.00K(+261.5%)
$263.00K(+55.6%)
Mar 2012
-
$26.00K(-81.8%)
$169.00K(+5533.3%)
Dec 2011
$3000.00(-99.9%)
$143.00K(>+9900.0%)
$3000.00(+113.0%)
Sep 2011
-
$0.00(0.0%)
-$23.00K(-100.5%)
Jun 2011
-
$0.00(+100.0%)
$4.82M(+0.7%)
Mar 2011
-
-$140.00K(-219.7%)
$4.78M(+3.1%)
Dec 2010
$4.64M(+98.7%)
$117.00K(-97.6%)
$4.64M(-0.8%)
Sep 2010
-
$4.84M(>+9900.0%)
$4.68M(+8728.3%)
Jun 2010
-
-$33.00K(+88.4%)
$53.00K(-95.0%)
Mar 2010
-
-$284.00K(-282.1%)
$1.06M(-54.6%)
Dec 2009
$2.33M(-80.7%)
$156.00K(-27.1%)
$2.33M(+12.0%)
Sep 2009
-
$214.00K(-78.0%)
$2.08M(-37.9%)
Jun 2009
-
$974.00K(-1.7%)
$3.35M(-56.1%)
Mar 2009
-
$991.00K(+1143.2%)
$7.65M(-36.8%)
Dec 2008
$12.10M
-$95.00K(-106.4%)
$12.10M(-17.6%)
DateAnnualQuarterlyTTM
Sep 2008
-
$1.48M(-71.8%)
$14.69M(+12.9%)
Jun 2008
-
$5.27M(-3.3%)
$13.01M(-37.2%)
Mar 2008
-
$5.45M(+118.7%)
$20.72M(+343.1%)
Dec 2007
$4.67M(+806.0%)
$2.49M(+1370.4%)
$4.67M(-60.6%)
Sep 2007
-
-$196.00K(-101.5%)
$11.87M(+6.0%)
Jun 2007
-
$12.98M(+222.5%)
$11.20M(+1754.5%)
Mar 2007
-
-$10.60M(-209.4%)
-$677.00K(-231.2%)
Dec 2006
$516.00K(-79.0%)
$9.69M(+1217.3%)
$516.00K(-93.6%)
Sep 2006
-
-$867.00K(-178.9%)
$8.08M(+364.1%)
Jun 2006
-
$1.10M(+111.7%)
-$3.06M(+50.2%)
Mar 2006
-
-$9.40M(-154.5%)
-$6.14M(-349.5%)
Dec 2005
$2.46M(+107.3%)
$17.25M(+243.7%)
$2.46M(+105.0%)
Sep 2005
-
-$12.01M(-504.7%)
-$49.18M(-44.7%)
Jun 2005
-
-$1.99M(-149.8%)
-$33.98M(+0.1%)
Mar 2005
-
-$795.00K(+97.7%)
-$34.00M(-1.3%)
Dec 2004
-$33.55M(-1063.6%)
-$34.39M(-1176.4%)
-$33.55M(>-9900.0%)
Sep 2004
-
$3.19M(+258.8%)
$145.00K(+126.2%)
Jun 2004
-
-$2.01M(-483.2%)
-$553.00K(-114.2%)
Mar 2004
-
-$345.00K(+50.2%)
$3.89M(+11.8%)
Dec 2003
$3.48M(+191.2%)
-$693.00K(-127.8%)
$3.48M(+2.5%)
Sep 2003
-
$2.50M(+2.6%)
$3.40M(+375.1%)
Jun 2003
-
$2.43M(+422.3%)
-$1.24M(+72.1%)
Mar 2003
-
-$755.00K(+3.0%)
-$4.43M(-15.9%)
Dec 2002
-$3.82M(-2571.3%)
-$778.00K(+63.6%)
-$3.82M(-24.6%)
Sep 2002
-
-$2.13M(-180.6%)
-$3.06M(-211.2%)
Jun 2002
-
-$761.00K(-421.2%)
-$985.00K(-313.9%)
Mar 2002
-
-$146.00K(-534.8%)
-$238.00K(-66.4%)
Dec 2001
-$143.00K(-104.2%)
-$23.00K(+58.2%)
-$143.00K(+17.8%)
Sep 2001
-
-$55.00K(-292.9%)
-$174.00K(-10.8%)
Jun 2001
-
-$14.00K(+72.5%)
-$157.00K(+40.1%)
Mar 2001
-
-$51.00K(+5.6%)
-$262.00K(-107.7%)
Dec 2000
$3.42M(+148.9%)
-$54.00K(-42.1%)
$3.42M(+298.5%)
Sep 2000
-
-$38.00K(+68.1%)
-$1.72M(+38.1%)
Jun 2000
-
-$119.00K(-103.3%)
-$2.79M(+9.2%)
Mar 2000
-
$3.63M(+169.9%)
-$3.07M(+56.2%)
Dec 1999
-$7.00M(-1066.7%)
-$5.20M(-372.7%)
-$7.00M(-268.4%)
Sep 1999
-
-$1.10M(-175.0%)
-$1.90M(-90.0%)
Jun 1999
-
-$400.00K(-33.3%)
-$1.00M(-145.5%)
Mar 1999
-
-$300.00K(-200.0%)
$2.20M(+466.7%)
Dec 1998
-$600.00K(-109.4%)
-$100.00K(+50.0%)
-$600.00K(0.0%)
Sep 1998
-
-$200.00K(-107.1%)
-$600.00K(-140.0%)
Jun 1998
-
$2.80M(+190.3%)
$1.50M(-11.8%)
Mar 1998
-
-$3.10M(-3000.0%)
$1.70M(-73.4%)
Dec 1997
$6.40M(+288.2%)
-$100.00K(-105.3%)
$6.40M(-1.5%)
Sep 1997
-
$1.90M(-36.7%)
$6.50M(+160.0%)
Jun 1997
-
$3.00M(+87.5%)
$2.50M(+1350.0%)
Mar 1997
-
$1.60M(+176.2%)
-$200.00K(+88.9%)
Dec 1996
-$3.40M(-1800.0%)
-
-
Sep 1996
-
-$2.10M(-800.0%)
-$1.80M(-1000.0%)
Jun 1996
$200.00K(0.0%)
$300.00K(+250.0%)
$200.00K(-85.7%)
Mar 1996
-
-$200.00K(-200.0%)
$1.40M(-12.5%)
Dec 1995
-
$200.00K(+300.0%)
$1.60M(+366.7%)
Sep 1995
-
-$100.00K(-106.7%)
-$600.00K(-400.0%)
Jun 1995
$200.00K(+110.0%)
$1.50M(>+9900.0%)
$200.00K(+115.4%)
Mar 1995
-
$0.00(+100.0%)
-$1.30M(0.0%)
Dec 1994
-
-$2.00M(-385.7%)
-$1.30M(-8.3%)
Sep 1994
-
$700.00K(>+9900.0%)
-$1.20M(+40.0%)
Jun 1994
-$2.00M
$0.00(0.0%)
-$2.00M(0.0%)
Mar 1994
-
$0.00(+100.0%)
-$2.00M(0.0%)
Dec 1993
-
-$1.90M(-1800.0%)
-$2.00M(-1900.0%)
Sep 1993
-
-$100.00K
-$100.00K

FAQ

  • What is Moderna, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Moderna, Inc.?
  • What is Moderna, Inc. annual cash from investing year-on-year change?
  • What is Moderna, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Moderna, Inc.?
  • What is Moderna, Inc. quarterly cash from investing year-on-year change?
  • What is Moderna, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Moderna, Inc.?
  • What is Moderna, Inc. TTM cash from investing year-on-year change?

What is Moderna, Inc. annual cash from investing?

The current annual cash from investing of MRNA is $1.95B

What is the all-time high annual cash from investing for Moderna, Inc.?

Moderna, Inc. all-time high annual cash from investing is $4.21B

What is Moderna, Inc. annual cash from investing year-on-year change?

Over the past year, MRNA annual cash from investing has changed by -$2.26B (-53.66%)

What is Moderna, Inc. quarterly cash from investing?

The current quarterly cash from investing of MRNA is $700.00M

What is the all-time high quarterly cash from investing for Moderna, Inc.?

Moderna, Inc. all-time high quarterly cash from investing is $2.01B

What is Moderna, Inc. quarterly cash from investing year-on-year change?

Over the past year, MRNA quarterly cash from investing has changed by -$21.00M (-2.91%)

What is Moderna, Inc. TTM cash from investing?

The current TTM cash from investing of MRNA is $1.46B

What is the all-time high TTM cash from investing for Moderna, Inc.?

Moderna, Inc. all-time high TTM cash from investing is $4.21B

What is Moderna, Inc. TTM cash from investing year-on-year change?

Over the past year, MRNA TTM cash from investing has changed by -$495.00M (-25.38%)
On this page